Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03684109 · ClinicalTrials.gov registry record · NA
Non-invasive Glioma Characterization Through Molecular Imaging
A NA study of Glioma and Brain Tumor, sponsored by University of Miami.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT03684109 is a NA study of Glioma and Brain Tumor that is actively recruiting participants, run by University of Miami. The registered enrollment target is 30 participants, below the 210-participant average among 87 other Glioma trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03684109, a NA study of Glioma and Brain Tumor, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
MRI-based sequences can provide non-invasive quantification of intratumoral 2-hydroxyglutarate (2HG) distribution and tumor cellularity in human gliomas and help guide the development of novel glioma therapies.
Conditions Studied
Interventions
- DEVICE 3T MRI Scanner
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-01-25 |
| Est. Completion | 2026-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03684109
The ClinicalTrials.gov registry entry for NCT03684109 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 210-participant average among 87 other Glioma trials with a reported enrollment target (86% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Glioma appearing as the primary indexed condition, and to 1 intervention - of which 3T MRI Scanner is the first listed.
NCT03684109 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT03684109 about?
NCT03684109 is a clinical study titled "Non-invasive Glioma Characterization Through Molecular Imaging". MRI-based sequences can provide non-invasive quantification of intratumoral 2-hydroxyglutarate (2HG) distribution and tumor cellularity in human gliomas and help guide the development of novel glioma therapies.
What is the current status of trial NCT03684109?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2019-01-25. Estimated completion is 2026-01-31.
What conditions does trial NCT03684109 study?
This clinical trial studies the following conditions: Glioma, Brain Tumor, Malignant Glioma, Primary Brain Tumor, Malignant Primary Brain Tumor.
What interventions are being tested in trial NCT03684109?
The interventions under investigation include: 3T MRI Scanner (DEVICE).
Who is sponsoring clinical trial NCT03684109?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03684109 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glioma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Tumor Treating Fields for the Treatment of Brainstem Gliomas
RECRUITING · NA
-
ASCENT Intervention for Brain Tumor Patients
RECRUITING · NA
-
LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
RECRUITING · NA
-
A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma
RECRUITING · NA
-
LITT Followed by Hypofractionated RT for Recurrent Gliomas
RECRUITING · NA
-
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.